Regulation2 min read

Cannabis Stocks Rally on Federal Reclassification Speculation

Marijuana equities climb as rescheduling rumors circulate, potentially reshaping sector tax burden and banking access across multi-state operators.

April 22, 2026 at 9:01 PMCannabismarketcap

Cannabis equities posted sharp gains as reports circulated that federal authorities may advance marijuana rescheduling from Schedule I to Schedule III under the Controlled Substances Act. The move would represent the most substantive federal cannabis policy shift in decades, directly impacting how multi-state operators structure their finances and operations.

Rescheduling to Schedule III would eliminate the punitive 280E tax provision that currently prevents cannabis companies from deducting standard business expenses. This tax burden has compressed margins across the sector, with operators like Curaleaf (CURLF), Green Thumb Industries (GTBIF), and Trulieve (TCNNF) paying effective tax rates exceeding 70% in some quarters. Relief from 280E could immediately boost bottom-line performance across licensed operators.

The regulatory development also signals potential progress on banking access, as financial institutions remain hesitant to serve cannabis businesses under current federal scheduling. Schedule III classification would likely accelerate institutional banking relationships and reduce the cash-intensive nature of cannabis operations, improving working capital management for operators managing hundreds of dispensary locations.

Investor enthusiasm reflects years of anticipation around federal reform, though implementation timelines remain uncertain. The rescheduling process involves multiple federal agencies and public comment periods that could extend beyond 2024. Previous reform speculation has generated similar rallies that subsequently faded without concrete policy changes, highlighting the volatility inherent in regulatory-dependent sectors.

Market dynamics continue favoring established multi-state operators with diversified geographic footprints and strong balance sheets. These companies stand to benefit most from federal tax relief, as they currently face the highest absolute 280E burdens. Smaller operators and single-state players may see less immediate impact, though improved banking access would benefit the entire licensed cannabis ecosystem.